Ping Jin

6.4k total citations · 1 hit paper
125 papers, 4.4k citations indexed

About

Ping Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ping Jin has authored 125 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 46 papers in Oncology and 39 papers in Immunology. Recurrent topics in Ping Jin's work include CAR-T cell therapy research (31 papers), Immunotherapy and Immune Responses (20 papers) and Mesenchymal stem cell research (18 papers). Ping Jin is often cited by papers focused on CAR-T cell therapy research (31 papers), Immunotherapy and Immune Responses (20 papers) and Mesenchymal stem cell research (18 papers). Ping Jin collaborates with scholars based in United States, China and South Korea. Ping Jin's co-authors include David F. Stroncek, Ena Wang, Francesco M. Marincola, Jiaqiang Ren, Gynheung An, Marianna Sabatino, Monica C. Panelli, Sara Civini, Jakyung Yi and Hee Joong Jeong and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Ping Jin

122 papers receiving 4.3k citations

Hit Papers

NAFLD causes selective CD... 2016 2026 2019 2022 2016 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ping Jin 2.0k 1.1k 974 670 538 125 4.4k
Ulrike Fiedler 3.2k 1.6× 796 0.7× 818 0.8× 587 0.9× 151 0.3× 67 4.9k
Ling Wu 2.2k 1.1× 1.5k 1.4× 1.3k 1.3× 663 1.0× 344 0.6× 74 4.9k
Ningyan Zhang 1.8k 0.9× 840 0.8× 1.1k 1.2× 338 0.5× 211 0.4× 122 4.7k
Serge Lichtsteiner 4.2k 2.1× 651 0.6× 734 0.8× 366 0.5× 407 0.8× 14 6.9k
David S. Ucker 2.3k 1.1× 1.5k 1.4× 649 0.7× 385 0.6× 1.6k 2.9× 61 5.1k
Qiang Wu 2.9k 1.4× 1.2k 1.1× 1.2k 1.2× 839 1.3× 202 0.4× 174 5.4k
Sophie Torrekens 2.7k 1.4× 370 0.3× 532 0.5× 607 0.9× 321 0.6× 53 4.7k
Daniel Hohl 4.3k 2.2× 966 0.9× 828 0.9× 464 0.7× 295 0.5× 167 8.7k
Michel Simon 1.7k 0.8× 1.1k 1.0× 505 0.5× 387 0.6× 264 0.5× 142 5.9k
J. Philip McCoy 2.1k 1.1× 796 0.7× 830 0.9× 721 1.1× 222 0.4× 99 4.4k

Countries citing papers authored by Ping Jin

Since Specialization
Citations

This map shows the geographic impact of Ping Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Jin more than expected).

Fields of papers citing papers by Ping Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Jin. The network helps show where Ping Jin may publish in the future.

Co-authorship network of co-authors of Ping Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Jin. A scholar is included among the top collaborators of Ping Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Jin. Ping Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Underwood, Sarah, Jianjian Jin, Lipei Shao, et al.. (2024). T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function. ImmunoHorizons. 8(6). 404–414. 1 indexed citations
2.
Procházková, Michaela, Yihua Cai, Rongye Shi, et al.. (2024). Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy. Cytotherapy. 27(3). 400–409. 3 indexed citations
3.
Shao, Lipei, S. Lawrence Bailey, Terry Gernsheimer, et al.. (2024). T-Cell Transcriptomic Signatures in Adults with Primary Untreated Immune Thrombocytopenia Segregate By Age, Revealing Distinct Druggable Pathways. Blood. 144(Supplement 1). 124–124. 1 indexed citations
4.
Dreyzin, Alexandra, Yihua Cai, Kyu Lee Han, et al.. (2024). Early Leukapheresis in Patients with B-ALL Yields an Activated, Early Memory T-Cell Phenotype Associated with Response to CAR T-Cell Therapy. Blood. 144(Supplement 1). 4853–4853. 1 indexed citations
5.
Jin, Ping, et al.. (2023). Hereditary spastic paraplegia (SPG 48) with deafness and azoospermia: A case report. Frontiers in Neurology. 14. 1156100–1156100. 2 indexed citations
6.
Song, Hannah, Alka Dwivedi, Sarah Underwood, et al.. (2023). Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output. Molecular Therapy — Methods & Clinical Development. 32(1). 101171–101171. 7 indexed citations
7.
Cai, Yihua, Michaela Procházková, Yongsoo Kim, et al.. (2023). Assessment and comparison of viability assays for cellular products. Cytotherapy. 26(2). 201–209. 10 indexed citations
8.
Ma, Jinxia, Lipei Shao, Hui Liu, et al.. (2023). Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays. Cytotherapy. 25(6). 598–604. 8 indexed citations
9.
Dreyzin, Alexandra, Sandhya R. Panch, Haneen Shalabi, et al.. (2022). Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells. Molecular Therapy — Methods & Clinical Development. 28. 51–61. 9 indexed citations
10.
Zhang, Shuangyin, et al.. (2019). lncRNA SRA1 Promotes the Activation of Cardiac Myofibroblasts Through Negative Regulation of miR-148b. DNA and Cell Biology. 38(4). 385–394. 16 indexed citations
11.
Jin, Ping, Wenjing Chen, Jiaqiang Ren, et al.. (2018). Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells. Cytotherapy. 20(5). 728–739. 1 indexed citations
12.
Wang, Bing, Lianghai Li, Ping Jin, Mengqiu Li, & Jianguo Li. (2017). Hesperetin protects against inflammatory response and cardiac fibrosis in postmyocardial infarction mice by inhibiting nuclear factor κB signaling pathway. Experimental and Therapeutic Medicine. 14(3). 2255–2260. 31 indexed citations
13.
Ren, Jiaqiang, David F. Stroncek, Yingdong Zhao, et al.. (2013). Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: Molecular changes associated with BMSC senescence. Stem Cell Research. 11(3). 1060–1073. 52 indexed citations
14.
Jin, Ping, et al.. (2012). Targets and research ideas for chemoprevention of cancer by Chinese medicine. Zhonghua zhongyiyao zazhi. 27(12). 3015–3018. 1 indexed citations
15.
Goessling, Wolfram, Xiao Guan, Ping Jin, et al.. (2011). Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models. Cell stem cell. 8(4). 445–458. 201 indexed citations
16.
Stroncek, David F., Ping Jin, Jiaqiang Ren, et al.. (2010). Quality assessment of cellular therapies: the emerging role of molecular assays. The Korean Journal of Hematology. 45(1). 14–14. 10 indexed citations
17.
Jin, Ping. (2008). The influence of short-term intensive insulin therapy on β-cell function in newly diagnosed type 2 diabetes. 1 indexed citations
18.
Zhao, Yingdong, Ping Jin, Monica C. Panelli, et al.. (2006). Common Cancer Biomarkers. Cancer Research. 66(6). 2953–2961. 84 indexed citations
19.
Jin, Ping, Ena Wang, Maurizio Provenzano, et al.. (2006). Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets. Journal of Translational Medicine. 4(1). 26–26. 39 indexed citations
20.
Panelli, Monica C., Ena Wang, Vladia Monsurrò, et al.. (2004). Overview of melanoma vaccines and promising approaches. Current Oncology Reports. 6(5). 414–420. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026